EWA
ZOM

EverSource Wealth Advisors’s Zomedica Corp. ZOM Stock Holding History

EverSource Wealth Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$1 – 4527
2025
Q4 		$1 Buy
+10
New +$1 ﹤0.01% 4267
2023
Q1 		– Sell
-300
Closed -$49 – 2599
2022
Q4 		$49 Hold
300
– – ﹤0.01% 2283
2022
Q3 		$0 Hold
300
– – ﹤0.01% 2213
2022
Q2 		$0 Buy
+300
New +$76 ﹤0.01% 1959

Other funds holding ZOM

JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GCP
Gill Capital Partners Denver, Colorado $348M AUM 14.74% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.6B AUM 18.62% 1-Year Est. Return

EverSource Wealth Advisors's ZOM Position: Q1 2026 in Review

EverSource Wealth Advisors sold out of Zomedica Corp. (ZOM) in Q1 2026, closing a stake of 10 shares — an estimated $1 sold.

EverSource Wealth Advisors first reported a position in ZOM in Q2 2022 and held it in 4 quarters. The position peaked at $49 in Q4 2022. 8 funds tracked by Wall St. Rank hold ZOM as of Q1 2026.

  • EverSource Wealth Advisors reported no remaining Zomedica Corp. position as of Q1 2026 after selling out during the quarter.
  • EverSource Wealth Advisors sold 10 Zomedica Corp. shares in Q1 2026, an estimated $1.
  • EverSource Wealth Advisors first reported a position in Zomedica Corp. in Q2 2022 and held it in 4 quarters.
  • EverSource Wealth Advisors's Zomedica Corp. position peaked at $49 in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.